Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study

FIB-4 staging alone resulted in optimal clinical outcomes and was cost-effective. Treatment for chronic HCV should not be delayed while awaiting fibrosis staging with TE.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2024-11-13
DOI
https://doi.org/10.1093/cid/ciae485
Citations
1
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study

Rachel Epstein, Tannishtha Pramanick, Laurent Castéra, Dimitri Baptiste et al.
1 citations
Clinical Infectious Diseases
Hepatitis C virus research
0.37
article

Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study

Rachel Epstein, Tannishtha Pramanick, Laurent Castéra, Dimitri Baptiste, Philip A. Chan, Patrick Duryea, Aurielle Thomas, Benjamin P. Linas, Benjamin Buzzee, Lynn E. Taylor, Richard K. Sterling, Matthew Carroll, Sarah Munroe, Jordan J. Feld
article en
1 citations

Abstract

FIB-4 staging alone resulted in optimal clinical outcomes and was cost-effective. Treatment for chronic HCV should not be delayed while awaiting fibrosis staging with TE.

Clinical Infectious DiseasesVol. 80(2)
Boston University (US), Boston Medical Center (US), Rhode Island Department of Health (US), University Health Network (CA), University of Rhode Island (US), Virginia Commonwealth University (US), University of Toronto (CA), Providence College (US), Université Paris Cité (FR), Brown University (US), Hôpital Beaujon (FR), Assistance Publique – Hôpitaux de Paris (FR), Toronto Liver Centre (CA)
Patrick and Catherine Weldon Donaghue Medical Research Foundation, Gilead Sciences, Boston University, Charles A. King Trust, National Institutes of Health, Center for AIDS Research, University of Washington, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development, National Institute of Dental and Craniofacial Research, National Institute on Minority Health and Health Disparities
Good health and well-being
Openalex Percentile: Top 35%
Hepatitis C virus research
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.